Immunyx Pharma Revenue

Biotechnology Research • Manhattan, New York, United States • 1-10 Employees

Immunyx Pharma revenue & valuation

Annual revenue	$513,330
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$1,700,000
Total funding	No funding

Key Contacts at Immunyx Pharma

Seth Salpeter

Co-Founder & Ceo

Zvika Granot

Cso & Co-Founder

Meital Naim

Director Of Pre-Clinical Development

Zvi Fridlender

Co-Founder & Cmo

Company overview

Headquarters	Manhattan, New York, United States
Website	immunyx.com
NAICS	541714
Founded	2021
Employees	1-10
Socials

Immunyx Pharma Email Formats

Immunyx Pharma uses 1 email format. The most common is {first initial} (e.g., j@immunyx.com), used 100% of the time.

Format	Example	Percentage
{first initial}	j@immunyx.com	100%

About Immunyx Pharma

Immunyx Pharma is focused on changing the landscape of immune modulation by targeting neutrophil toxicity in numerous chronic diseases. The company was built by world leaders in neutrophil biology and nanoparticle delivery to use a targeted neutrophil nanoparticle platform (TENNs) to solve the significant issues in neutrophil therapy. While big pharma has invested heavily in neutrophil targeted drugs, they have failed to bring solutions to the clinic due to the danger of causing neutropenia and the difficulty of modulating such a large & dynamic population of cells. Our TENN platform is intended to manipulate neutrophil toxic behavior without destroying their disease fighting function, while bringing a concentrated payload of drug to all neutrophils throughout the body with a long bioavailability. We are currently focusing on applying our platform to modulate neutrophil activity in cancer and inflammatory disease.

Employees by Management Level

Total employees: 1-10

Seniority

Employees

C-Suite

Director

Entry

Employees by Department

Immunyx Pharma has 4 employees across 2 departments.

Departments

Number of employees

Funding Data

Immunyx Pharma has never raised funding before.

Immunyx Pharma Tech Stack

Discover the technologies and tools that power Immunyx Pharma's digital infrastructure, from frameworks to analytics platforms.

reCAPTCHA

Security

jQuery UI

JavaScript libraries

Elementor

Page builders

jQuery Migrate

JavaScript libraries

Cloudflare

CDN

Twitter Emoji

Font scripts

jQuery

JavaScript libraries

HTTP/3

Miscellaneous

HSTS

Security

PHP

Programming languages

WordPress

Blogs

Bootstrap

UI frameworks

Frequently asked questions

Immunyx Pharma is located in Manhattan, New York, US.

Immunyx Pharma generates an estimated annual revenue of $513,330. This revenue figure reflects the company's market position and business performance in its industry.

Immunyx Pharma has an estimated valuation of $1,700,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

Immunyx Pharma was founded in 2021, making it 5 years old. The company has established itself as a significant player in its industry over this time.

Immunyx Pharma has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.

Key Contacts at Immunyx Pharma

Seth Salpeter

Co-Founder & Ceo

Zvika Granot

Cso & Co-Founder

Meital Naim

Director Of Pre-Clinical Development

Zvi Fridlender

Co-Founder & Cmo

4.8

40,000 users